Berlin
Germany
26
2021-03-18
17
2023-02-14
These are the the leading inventors for applications assigned to MOLOGEN AG:
MOLOGEN AG based in Berlin, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
TLR-9 AGONISTS FOR MODULATION OF TUMOR MICROENVIRONMENT
#2 | 2021-01-14 ✅ Patent 11,578,331 granted on 2023-02-14Combination comprising immunostimulatory oligonucleotides
#3 | 2020-12-10BIOMARKER FOR SMALL CELL LUNG CANCER THERAPY
#4 | 2020-07-23 ✅ Patent 11,583,581 granted on 2023-02-21Methods of treating a retroviral infection
#5 | 2019-10-17 ✅ Patent 10,604,760 granted on 2020-03-31Combination comprising immunostimulatory oligonucleotides
#6 | 2018-09-06 ✅ Patent 10,487,333 granted on 2019-11-26Combination comprising immunostimulatory oligonucleotides
#7 | 2016-12-01 ✅ Patent 10,280,424 granted on 2019-05-07Covalently closed non-coding immunomodulatory DNA construct
#8 | 2016-11-22 ✅ Patent 9,499,815 granted on 2016-11-22Multimer for immunostimulation
#9 | 2016-04-28 ✅ Patent 10,006,032 granted on 2018-06-26Predictive biomarker for cancer therapy
#10 | 2015-11-19Means for Eliciting an Immune Response and a Method Transfer
#11 | 2015-02-19Means for Eliciting an Immune Response and a Method Therefor
#12 | 2014-01-09Non-Coding Immunomodulatory DNA Construct
#13 | 2013-10-17 ✅ Patent 9,375,435 granted on 2016-06-28Use of a DNA expression construct
#14 | 2012-04-19Concatamers for Immunemodulation
#15 | 2011-09-15 ✅ Patent 8,669,100 granted on 2014-03-11DNA expression constructs encoding the antigens thiol-specific antioxidant protein and kinetoplastid membrane protein
#16 | 2010-12-02CATENATE FOR IMMUNOSTIMULATION
#17 | 2010-11-25 ✅ Patent 9,345,754 granted on 2016-05-24Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
#18 | 2009-09-03FUNCTIONAL IN VITRO IMMUNOASSAY
#19 | 2009-02-26 ✅ Patent 9,212,366 granted on 2015-12-15Immune modulating oligonucleotides in connection with chemotherapeutic measures
#20 | 2009-01-01Method for the Production of Suitable Dna Constructs for Specific Inhibition of Gene Expression by Rna Interference
#21 | 2008-12-18 ✅ Patent 9,012,620 granted on 2015-04-21DNA constructs for specific inhibition of gene expression by RNA interference
#22 | 2007-07-12 ✅ Patent 7,635,468 granted on 2009-12-22Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
#23 | 2007-03-01 ✅ Patent 8,017,591 granted on 2011-09-13Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals
#24 | 2006-10-26 ✅ Patent 7,915,035 granted on 2011-03-29Vaccine against oncovirus infections such as infections by feline leukosis virus of the cat
#25 | 2006-08-31 ✅ Patent 7,795,406 granted on 2010-09-14Agent for treating leishmania infections
#26 | 2006-07-11 ✅ Patent 7,074,772 granted on 2006-07-11Design principle for the construction of expression constructs for gene therapy
Also check out Mologen AG's (Berlin, Germany) applicant profile with 4 patent applications submitted.
42601 ⎘